The Department of Drug Administration (DDA) granted the approval for the use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.
The DDA has already given permission for the use of Sinopharm COVID-19 vaccine (commonly understood as Vero Cell in Nepal), another Chinese COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
China has provided 1.8 million doses of Sinopharm COVID-19 vaccine as grant assistance to Nepal.
World Health Organisation (WHO) has listed both the COVID-19 vaccines for emergency use, giving the green light for these vaccines to be rolled out globally.
- Indian PM Modi, President Joe Biden Hold First Bilateral Meeting At White House
- Sep 24, 2021
- China Criticizes Quad Ahead Of Summit
- Sep 24, 2021
- Import Of Chinese Made Vehicles From Rasuwagadhi Border Increases
- Sep 23, 2021
- Nepal’s Remittance Inflow Decline By 18.1 Percent
- Sep 23, 2021
- Indian PM Modi In US To Address UNGA Summit And To Attend High Level Meeting In Washington
- Sep 23, 2021
